Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · IEX Real-Time Price · USD
4.510
-0.090 (-1.96%)
At close: Jul 19, 2024, 4:00 PM
4.370
-0.140 (-3.10%)
Pre-market: Jul 22, 2024, 7:31 AM EDT
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $82.16 million as of July 22, 2024. Its market cap has decreased by -23.72% in one year.
Market Cap
82.16M
Enterprise Value
61.71M
1-Year Change
-23.72%
Ranking
Category
Stock Price
$4.51
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $82.16M, a decrease of -60.64%. That is a compound annual growth rate of -30.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 82.20M | -8.87% |
| Dec 29, 2023 | 90.20M | -9.98% |
| Dec 30, 2022 | 100.20M | -48.08% |
| Dec 31, 2021 | 193.00M | -7.55% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AlloVir | 85.64M |
| CASI Pharmaceuticals | 85.23M |
| Verastem | 84.08M |
| AN2 Therapeutics | 83.22M |
| Sangamo Therapeutics | 82.40M |
| Instil Bio | 82.08M |
| BioAtla | 81.80M |
| Serina Therapeutics | 81.70M |